• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肠道病毒 71 的耐利巴韦林突变体在细胞培养中生长时表现出高复制保真度表型。

Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture.

机构信息

Infectious Diseases and Immunology, Sydney Medical School, University of Sydney, New South Wales, Australia.

出版信息

J Virol. 2013 Feb;87(3):1759-69. doi: 10.1128/JVI.02139-12. Epub 2012 Nov 21.

DOI:10.1128/JVI.02139-12
PMID:23175376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3554166/
Abstract

It has been shown in animal models that ribavirin-resistant poliovirus with a G64S mutation in its 3D polymerase has high replication fidelity coupled with attenuated virulence. Here, we describe the effects of mutagenesis in the human enterovirus 71 (HEV71) 3D polymerase on ribavirin resistance and replication fidelity. Seven substitutions were introduced at amino acid position 3D-G64 of a HEV71 full-length infectious cDNA clone (26M). Viable clone-derived virus populations were rescued from the G64N, G64R, and G64T mutant cDNA clones. The clone-derived G64R and G64T mutant virus populations were resistant to growth inhibition in the presence of 1,600 μM ribavirin, whereas the growth of parental 26M and the G64N mutant viruses were inhibited in the presence of 800 μM ribavirin. Nucleotide sequencing of the 2C and 3D coding regions revealed that the rate of random mutagenesis after 13 passages in the presence of 400 μM ribavirin was nearly 10 times higher in the 26M genome than in the mutant G64R virus genome. Furthermore, random mutations acquired in the 2C coding regions of 26M and G64N conferred resistance to growth inhibition in the presence of 0.5 mM guanidine, whereas the G64R and G64T mutant virus populations remained susceptible to growth inhibition by 0.5 mM guanidine. Interestingly, a S264L mutation identified in the 3D coding region of 26M after ribavirin selection was also associated with both ribavirin-resistant and high replication fidelity phenotypes. These findings are consistent with the hypothesis that the 3D-G64R, 3D-G64T, and 3D-S264L mutations confer resistance upon HEV71 to the antiviral mutagen ribavirin, coupled with a high replication fidelity phenotype during growth in cell culture.

摘要

在动物模型中已经表明,具有 3D 聚合酶 G64S 突变的耐利巴韦林脊髓灰质炎病毒具有高复制保真度和减弱的毒力。在这里,我们描述了人肠道病毒 71(HEV71)3D 聚合酶中的突变对利巴韦林耐药性和复制保真度的影响。在 HEV71 全长感染性 cDNA 克隆(26M)的 3D-G64 氨基酸位置引入了七个取代。从 G64N、G64R 和 G64T 突变 cDNA 克隆中拯救出可存活的克隆衍生病毒群体。衍生的 G64R 和 G64T 突变病毒群体对 1600 μM 利巴韦林存在时的生长抑制具有抗性,而亲本 26M 和 G64N 突变病毒的生长在 800 μM 利巴韦林存在时受到抑制。2C 和 3D 编码区的核苷酸测序显示,在存在 400 μM 利巴韦林的情况下,经过 13 次传代后,26M 基因组中的随机突变率几乎是突变 G64R 病毒基因组的 10 倍。此外,在 26M 和 G64N 的 2C 编码区获得的随机突变赋予了对 0.5 mM 胍抑制生长的抗性,而 G64R 和 G64T 突变病毒群体仍然对 0.5 mM 胍的生长抑制敏感。有趣的是,在利巴韦林选择后在 26M 的 3D 编码区中鉴定的 S264L 突变也与利巴韦林耐药性和高复制保真度表型相关。这些发现与以下假设一致,即 3D-G64R、3D-G64T 和 3D-S264L 突变赋予 HEV71 对抗病毒诱变剂利巴韦林的抗性,并且在细胞培养物中生长时具有高复制保真度表型。

相似文献

1
Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture.人肠道病毒 71 的耐利巴韦林突变体在细胞培养中生长时表现出高复制保真度表型。
J Virol. 2013 Feb;87(3):1759-69. doi: 10.1128/JVI.02139-12. Epub 2012 Nov 21.
2
Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice.人肠道病毒 71 高复制保真度变异株在 AG129 小鼠中的衰减。
J Virol. 2014 May;88(10):5803-15. doi: 10.1128/JVI.00289-14. Epub 2014 Mar 12.
3
A study of the virulence in mice of high copying fidelity variants of human enterovirus 71.研究高复制保真度人肠道病毒 71 变异株在小鼠中的毒力。
Virus Res. 2013 Sep;176(1-2):265-72. doi: 10.1016/j.virusres.2013.06.019. Epub 2013 Jul 12.
4
Selection and characterisation of guanidine-resistant mutants of human enterovirus 71.人肠道病毒 71 型胍盐抗性突变株的筛选与鉴定。
Virus Res. 2012 Oct;169(1):72-9. doi: 10.1016/j.virusres.2012.07.005. Epub 2012 Jul 16.
5
Effects of glycine 64 substitutions in RNA-dependent RNA polymerase on ribavirin sensitivity and pathogenicity of coxsackievirus A6.甘氨酸 64 取代对依赖 RNA 的 RNA 聚合酶对肠道病毒 A6 利巴韦林敏感性和致病性的影响。
Virus Res. 2024 Jan 2;339:199268. doi: 10.1016/j.virusres.2023.199268. Epub 2023 Nov 16.
6
An Extended Primer Grip of Picornavirus Polymerase Facilitates Sexual RNA Replication Mechanisms.微小核糖核酸病毒聚合酶的延伸引物握法促进有性RNA复制机制
J Virol. 2020 Jul 30;94(16). doi: 10.1128/JVI.00835-20.
7
Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence.口蹄疫病毒的利巴韦林耐药变异体:准种多样性受限对病毒毒力的影响。
J Virol. 2014 Apr;88(8):4008-20. doi: 10.1128/JVI.03594-13. Epub 2014 Jan 22.
8
The molecular basis of mouse adaptation by human enterovirus 71.人肠道病毒71型对小鼠的适应性分子基础。
J Gen Virol. 2008 Jul;89(Pt 7):1622-1632. doi: 10.1099/vir.0.83676-0.
9
Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion.病毒聚合酶-解旋酶复合物调节复制保真度以克服细胞内核苷酸耗竭。
J Virol. 2015 Nov;89(22):11233-44. doi: 10.1128/JVI.01553-15. Epub 2015 Aug 26.
10
Foot-and-mouth disease virus low-fidelity polymerase mutants are attenuated.口蹄疫病毒低保真度聚合酶突变体减毒。
Arch Virol. 2014 Oct;159(10):2641-50. doi: 10.1007/s00705-014-2126-z. Epub 2014 Jun 3.

引用本文的文献

1
Enterovirus A71 priorities, challenges, and future opportunities in humoral immunity and vaccine development.肠道病毒A71在体液免疫和疫苗研发方面的重点、挑战及未来机遇
NPJ Vaccines. 2025 Aug 15;10(1):194. doi: 10.1038/s41541-025-01184-z.
2
Fidelity Characterization of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus and NADC30-like Strain.高致病性猪繁殖与呼吸综合征病毒和 NADC30 样毒株的保真度特征。
Viruses. 2024 May 16;16(5):797. doi: 10.3390/v16050797.
3
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?是否到了改用其他减毒活疫苗而非口服脊髓灰质炎减毒活疫苗来预防脊髓灰质炎的时候了?
Front Public Health. 2024 Jan 8;11:1284337. doi: 10.3389/fpubh.2023.1284337. eCollection 2023.
4
Research progress on pathogenic and therapeutic mechanisms of Enterovirus A71.肠道病毒 A71 的致病和治疗机制的研究进展。
Arch Virol. 2023 Sep 29;168(10):260. doi: 10.1007/s00705-023-05882-8.
5
Potential and action mechanism of favipiravir as an antiviral against Junin virus.法匹拉韦抗胡宁病毒的作用机制及潜力。
PLoS Pathog. 2022 Jul 11;18(7):e1010689. doi: 10.1371/journal.ppat.1010689. eCollection 2022 Jul.
6
Influence of Ribavirin on Mumps Virus Population Diversity.利巴韦林对腮腺炎病毒种群多样性的影响。
Viruses. 2021 Dec 17;13(12):2535. doi: 10.3390/v13122535.
7
Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs.抑制具有临床相关核苷酸类似物的病毒 RNA 依赖性 RNA 聚合酶。
Enzymes. 2021;49:315-354. doi: 10.1016/bs.enz.2021.07.002. Epub 2021 Oct 15.
8
From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution.从 RNA 世界到 SARS-CoV-2:RNA 病毒进化的编辑故事。
Cells. 2021 Jun 20;10(6):1557. doi: 10.3390/cells10061557.
9
Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase.利用工程化高保真病毒聚合酶开发遗传稳定的减毒流感活疫苗株。
J Virol. 2021 May 24;95(12). doi: 10.1128/JVI.00493-21.
10
Enterovirus A71 Vaccines.肠道病毒A71疫苗
Vaccines (Basel). 2021 Feb 27;9(3):199. doi: 10.3390/vaccines9030199.

本文引用的文献

1
Coxsackievirus B3 mutator strains are attenuated in vivo.柯萨奇病毒 B3 突变株在体内减毒。
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):E2294-303. doi: 10.1073/pnas.1204022109. Epub 2012 Aug 1.
2
Selection and characterisation of guanidine-resistant mutants of human enterovirus 71.人肠道病毒 71 型胍盐抗性突变株的筛选与鉴定。
Virus Res. 2012 Oct;169(1):72-9. doi: 10.1016/j.virusres.2012.07.005. Epub 2012 Jul 16.
3
In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection.利巴韦林和普乐可复抗肠道病毒 71 感染的体外和体内评价。
Arch Virol. 2012 Apr;157(4):669-79. doi: 10.1007/s00705-011-1222-6. Epub 2012 Jan 15.
4
Biochemical characterization of enterovirus 71 3D RNA polymerase.肠道病毒71型3D RNA聚合酶的生化特性
Biochim Biophys Acta. 2011 Mar;1809(3):211-9. doi: 10.1016/j.bbagrm.2011.01.001. Epub 2011 Jan 8.
5
Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China.肠道病毒 71 型 RNA 依赖性 RNA 聚合酶与底物和类似物复合物的结构为中国手足口病大流行提供了药物靶点。
Protein Cell. 2010 May;1(5):491-500. doi: 10.1007/s13238-010-0061-7. Epub 2010 Jun 4.
6
Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase.脊髓灰质炎病毒 RNA 依赖性 RNA 聚合酶活性位点关闭的结构基础。
Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22505-10. doi: 10.1073/pnas.1007626107. Epub 2010 Dec 10.
7
Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism.口蹄疫病毒 2C 是一种六聚体 AAA+ 蛋白,具有协调的 ATP 水解机制。
J Biol Chem. 2010 Aug 6;285(32):24347-59. doi: 10.1074/jbc.M110.129940. Epub 2010 May 27.
8
Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase.结构洞察口蹄疫病毒 RNA 依赖性 RNA 聚合酶的复制起始和延伸过程。
Curr Opin Struct Biol. 2009 Dec;19(6):752-8. doi: 10.1016/j.sbi.2009.10.016. Epub 2009 Nov 13.
9
The molecular basis of mouse adaptation by human enterovirus 71.人肠道病毒71型对小鼠的适应性分子基础。
J Gen Virol. 2008 Jul;89(Pt 7):1622-1632. doi: 10.1099/vir.0.83676-0.
10
Picornavirus RNA-dependent RNA polymerase.微小核糖核酸病毒RNA依赖性RNA聚合酶。
Int J Biochem Cell Biol. 2009 Mar;41(3):498-502. doi: 10.1016/j.biocel.2008.03.019. Epub 2008 Apr 7.